Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P.E. Lovat
Autophagy Modulation in MEK Inhibitor-Resistant Melanoma
British Journal of Dermatology
Dermatology
Medicine
利用自噬作用消除转移性黑色素瘤中的丝裂原活化蛋白激酶抑制剂诱导的耐药性
British Journal of Dermatology
Dermatology
Medicine
Related publications
Trametinib: A MEK Inhibitor for Management of Metastatic Melanoma
OncoTargets and Therapy
Oncology
Pharmacology
Why Do We Need a New BRAF-MEK Inhibitor Combination in Melanoma?
Oncology in Clinical Practice
Oncology
Noxa Upregulation by Oncogenic Activation of MEK/ERK Through CREB Promotes Autophagy in Human Melanoma Cells
Oncotarget
Oncology
Antitumor Activity of the Selective Pan-Raf Inhibitor TAK-632 in BRAF Inhibitor-Resistant Melanoma
Cancer Research
Cancer Research
Oncology
816 Autophagy Inhibition Sensitizes Targeted Therapy-Resistant Melanoma to MEK1/2 Inhibitors
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Antitumor Effects of the Investigational Selective MEK Inhibitor TAK733 Against Cutaneous and Uveal Melanoma Cell Lines
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Efficacy, Safety, and Tolerability of Approved Combination BRAF and MEK Inhibitor Regimens for BRAF-Mutant Melanoma
Cancers
Cancer Research
Oncology
UBE2N Promotes Melanoma Growth via MEK/FRA1/SOX10 Signaling
Cancer Research
Cancer Research
Oncology
Shipping Out MEK Inhibitor Resistance With SHP2 Inhibitors
Cancer Discovery
Oncology
